Matches in Nanopublications for { ?s ?p "Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD." ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- association label "Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD." assertion.
- association label "Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD." assertion.
- association label "Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD." assertion.
- association label "Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD." assertion.
- association label "Desipramine is a secondary amine tricyclic antidepressant that is FDA approved for the treatment of depression. This drug has off-label use to treat bulimia nervosa, irritable bowel syndrome, neuropathic pain, overactive bladder, post-herpetic neuralgia, and ADHD." assertion.